Menu
ncarol.com
  • Home
  • Business
  • Real Estate
  • Health
  • Services
  • Music
  • Beauty
  • Finance
  • Financial
ncarol.com

DG Meditech Opens Doors to North American Operations With Appointment of New Chief for Americas
ncarol.com/10139625

Trending...
  • Phinge CEO Ranked #1 Globally by Crunchbase for the Last Week, Will Be in Las Vegas Jan. 4-9, the Week of CES to Discuss Netverse & IPO Coming in 2026 - 105
  • "Micro-Studio": Why San Diegans are Swapping Crowded Gyms for Private, One-on-One Training at Sweat Society
  • Documentary "Prescription for Violence: Psychiatry's Deadly Side Effects" Premieres, Exposes Link Between Psychiatric Drugs and Acts of Mass Violence
DGMeditech
TRAVERSE CITY, Mich. & TORONTO - ncarol.com -- The DG Meditech today announced the appointment of Davis Gravelsins as Chief Executive Officer, US Operations. Previously working as Senior Liaison Digital Transition - Healthcare on projects in the Baltic and in the E.U., Mr. Gravelsins will now be heading up DG Meditech's service expansion into North and South American geographies.

Founded in Daugavpils, Latvia in 1989 as Derzins Glochsteinbacher Medicīnas Programmatūras Risinājumu Korporācija, (DGMPR Korp.) the company rebranded in 2020 as DG Meditech to expand into markets outside of Europe, where is known for its large service offering of digital transformation services, working with government and state-run corporate clientele in acute and long-term care, as well as in medical, therapeutic, homecare and behavioral areas.

Eying new international opportunities, the company opened offices in Traverse City, Michigan and Toronto, Canada prior to the onset of Covid-19, and has since built agile consulting teams in each city. These teams of consist of consultants, analysts, compliance experts and finance personnel who are working under Mr. Gravelsins to finance and manage new North American investment opportunities for DG Meditech's European clients.

More on ncarol.com
  • Guests Can Save 25 Percent Off Last Minute Bookings at KeysCaribbean's Village at Hawks Cay Villas
  • Trump's Executive Order Rescheduling Cannabis: Accelerating M&A in a Multibillion-Dollar Industry
  • Genuine Hospitality, LLC Selected to Operate Hilton Garden Inn Birmingham SE / Liberty Park
  • tukr box Ministries Launches Meal-Sharing Kit Partnership With Marry Me Marinara
  • Documentary "Prescription for Violence: Psychiatry's Deadly Side Effects" Premieres, Exposes Link Between Psychiatric Drugs and Acts of Mass Violence

Operating as DGMPR Korp. and now as DG Meditech, the company has provided digital transformation services including finance, purchasing and software solution optimization expertise for dozens of clients for over three decades, deploying some of the first EHR and IMS solutions in European state-run and private healthcare.

The company's clients include ACOs, hospitals, home care groups, Skilled Nursing Facilities, senior living organizations, along with many long-term care facilities and their government funding organizations.

"I am very excited to be heading up our expansion from Europe to the Americas. Many of our clients are well down the transformation path, and are now actively pursuing management and purchasing opportunities in Canada, the USA, Mexico, Brazil and Argentina. We are pleased to be part of this global drive to expand operations while digitally transforming client's portfolios." Said Mr. Gravelsins.

-        30  –

For more information, please contact us:

Toronto, Canada Office: Mr. D. Gravelsins

davis.gravelsins@dgmeditech.com

Travers City Office: Mr. J. Anson

janson@dgmeditech.com – 705-943-8225

Contact
Davis Gravelsins
***@dgmeditech.com


Source: DGMeditech

Show All News | Report Violation

0 Comments
1000 characters max.

Latest on ncarol.com
  • Renowned Alternative Medicine Specialist Dr. Sebi and His African Bio Mineral Balance Therapy Are the Focus of New Book
  • Psychiatric Drug Damage Ignored for Decades; CCHR Demands Federal Action
  • Why Millions Are Losing Sexual Sensation, And Why It's Not Age, Hormones, or Desire
  • Justin Jeansonne An Emerging Country Singer-Songwriter Music Fans Have Been Waiting For…a True Maverick
  • Russellville Huntington Learning Center Expands Access to Literacy Support; Approved Provider Under Arkansas Department of Education
  • UK Financial Ltd Launches U.S. Operations Following Delaware Approval
  • Pinealage: the app that turns strangers into meditation companions — in crowdfunding phase
  • "Micro-Studio": Why San Diegans are Swapping Crowded Gyms for Private, One-on-One Training at Sweat Society
  • Beycome Closes $2.5M Seed Round Led by InsurTech Fund
  • Tru by Hilton Columbia South Opens to Guests
  • Christy Sports donates $56K in new gear to SOS Outreach to help kids hit the slopes
  • "BigPirate" Sets Sail: A New Narrative-Driven Social Casino Adventure
  • Phinge CEO Ranked #1 Globally by Crunchbase for the Last Week, Will Be in Las Vegas Jan. 4-9, the Week of CES to Discuss Netverse & IPO Coming in 2026
  • Fayetteville Concrete Contractors Serves Cumberland County with Concrete Solutions
  • Women's Everyday Safety Is Changing - The Blue Luna Shows How
  • Microgaming Unveils Red Papaya: A New Studio Delivering Cutting-Edge, Feature-Rich Slots
  • 5-Star Duncan Injury Group Expands Personal Injury Representation to Arizona
  • NC State and Railinc Partner to Advance Freight Efficiency through Modal Rebalancing Study
  • The End of "Influencer" Gambling: Bonusetu Analyzes Finland's Strict New Casino Marketing Laws
  • AI-Driven Cybersecurity Leader Gains Industry Recognition, Secures $6M Institutional Investment, Builds Momentum Toward $16M Annual Run-Rate Revenue
_catLbl0 _catLbl1

Popular on ncarol.com

  • Liquidity Aggregation: US-Registered JHKXWL Integrates AI Analytics for Brazilian and Global Institutional Traders - 1333
  • Phinge CEO Ranked #1 Globally by Crunchbase for the Last Week, Will Be in Las Vegas Jan. 4-9, the Week of CES to Discuss Netverse & IPO Coming in 2026 - 105
  • "Micro-Studio": Why San Diegans are Swapping Crowded Gyms for Private, One-on-One Training at Sweat Society
  • Own 327 Acres of American Prime Real Estate with 2 Miles Waterfront Worth In Millions for Just $7 — Worldwide Raffle Launched
  • Record Revenue, Tax Tailwinds, and AI-Driven Scale: Why Off The Hook YS Inc. Is Emerging as a Standout in the $57 Billion U.S. Marine Market
  • VSee Health (N A S D A Q: VSEE) Secures $6.0M At-Market Investment, Accelerates Expansion as Revenues Surge
  • LaTerra and Respark Under Contract with AIMCO to Acquire a $455M, 7-Property Chicago Multifamily Portfolio
  • Crunchbase Ranks Phinge Founder & CEO Robert DeMaio #1 Globally. Meet him in Las Vegas-Week of CES to Learn About Netverse, Patented App-less Platform
  • Costa Oil - 10 Minute Oil Change Surpasses 70 Locations with Construction of San Antonio, TX Stores — Eyes Growth Via Acquisition or Being Acquired
  • Documentary "Prescription for Violence: Psychiatry's Deadly Side Effects" Premieres, Exposes Link Between Psychiatric Drugs and Acts of Mass Violence

Similar on ncarol.com

  • HBZBZL Unveils "Intelligent Ecosystem" Strategy: Integrating AI Analytics with Web3 Incubation
  • Trump's Executive Order Rescheduling Cannabis: Accelerating M&A in a Multibillion-Dollar Industry
  • Documentary "Prescription for Violence: Psychiatry's Deadly Side Effects" Premieres, Exposes Link Between Psychiatric Drugs and Acts of Mass Violence
  • Nextvisit Co-Founder Ryan Yannelli Identifies Six Critical Factors for Behavioral Health Providers Evaluating AI Scribes in 2026
  • Psychiatric Drug Damage Ignored for Decades; CCHR Demands Federal Action
  • Women's Everyday Safety Is Changing - The Blue Luna Shows How
  • Artificial Intelligence Leader Releases Children's Book on Veterans Day
  • CCHR Documentary Probes Growing Evidence Linking Psychiatric Drugs to Violence
  • New Jersey Therapy and Life Coaching Unveils Original Dan Fenelon Mural in Voorhees New Jersey Therapy Office
  • Terizza Forms Strategic Collaboration with UC San Diego to Pioneer Next-Generation Distributed AI Infrastructure
Copyright © 2025 ncarol.com | Contact Us | Privacy Policy | Terms of Service | Contribute